ANTI-TNF-ANTI-IL-17 BISPECIFIC ANTIBODIES

Bispecific antibodies are provided that specifically bind both Tumor Necrosis Factor alpha (TNFα) and Interleukin-17 (IL-17). The bispecific antibodies of the invention are useful for treating various autoimmune diseases, including Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA), and Ankylosing...

Full description

Saved in:
Bibliographic Details
Main Authors VENDEL, ANDREW CHARLES, WITCHER, DERRICK RYAN, GLASEBROOK, ANDREW LAWRENCE, ALLAN, BARRETT, LU, JIRONG, TANG, YING, LEUNG, DONMIENNE DOEN MUN, YACHI, PIA PAULIINA
Format Patent
LanguageEnglish
French
German
Published 13.01.2016
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Bispecific antibodies are provided that specifically bind both Tumor Necrosis Factor alpha (TNFα) and Interleukin-17 (IL-17). The bispecific antibodies of the invention are useful for treating various autoimmune diseases, including Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA), and Ankylosing Spondylitis (AS).
Bibliography:Application Number: EP20140711895